| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |